Little House Capital’s Biogen BIIB Stock Holding History

Little House Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-59	Closed	-$14.4K	–	107
2019 Q2	$14.4K	Sell	59 -40	-40%	-$9.24K	9.61%	1
2019 Q1	$23K	Buy	+99	New	+$31.2K	0.02%	197

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Little House Capital's BIIB Position: Q3 2019 in Review

Little House Capital sold out of Biogen (BIIB) in Q3 2019, closing a stake of 59 shares — an estimated $14.4K sold.

Little House Capital first reported a position in BIIB in Q1 2019 and held it in 2 quarters. The position peaked at $23K in Q1 2019. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Little House Capital reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Little House Capital sold 59 Biogen shares in Q3 2019, an estimated $14.4K.
Little House Capital first reported a position in Biogen in Q1 2019 and held it in 2 quarters.
Little House Capital's Biogen position peaked at $23K in Q1 2019.
988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Little House Capital's 13F filing for Q3 2019, filed 5 Nov 2019.